

Canopy Growth stock tumbles 9% after earnings and revenue miss estimates, despite strong cannabis sales and improving EBITDA.
You can purchase shares of Canopy Growth (NASDAQ:CGC) through any online brokerage.
Other companies in Canopy Growth’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Canopy Growth has a consensus price target of $2.00.
The stock price for Canopy Growth (NASDAQ: CGC) is $0.645 last updated November 6, 2026 at 7:55 PM EST.
There are no upcoming dividends for Canopy Growth.
Canopy Growth does not have any upcoming earnings scheduled.
There is no upcoming split for Canopy Growth.
Canopy Growth is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis...